203 related articles for article (PubMed ID: 35615981)
1. Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma.
Kumar D; Das M; Oberg A; Sahoo D; Wu P; Sauceda C; Jih L; Ellies LG; Langiewicz MT; Sen S; Webster NJG
Adv Sci (Weinh); 2022 Jul; 9(21):e2105120. PubMed ID: 35615981
[TBL] [Abstract][Full Text] [Related]
2. Deletion of serine/arginine-rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice.
Sen S; Langiewicz M; Jumaa H; Webster NJ
Hepatology; 2015 Jan; 61(1):171-83. PubMed ID: 25132062
[TBL] [Abstract][Full Text] [Related]
3. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
4. Degradation of splicing factor SRSF3 contributes to progressive liver disease.
Kumar D; Das M; Sauceda C; Ellies LG; Kuo K; Parwal P; Kaur M; Jih L; Bandyopadhyay GK; Burton D; Loomba R; Osborn O; Webster NJ
J Clin Invest; 2019 Aug; 129(10):4477-4491. PubMed ID: 31393851
[TBL] [Abstract][Full Text] [Related]
5. SCARB1-encoded circ _0029343 induces p73 splicing to promote growth and metastasis of hepatocellular carcinoma via miR-486-5p/SRSF3 axis.
Zhu S; Cao S; Che J; Zhao L; Su Z; Li D; Pei R; Xu L; Ding Y; Zhou W
J Biochem Mol Toxicol; 2024 Feb; 38(2):e23646. PubMed ID: 38345168
[TBL] [Abstract][Full Text] [Related]
6. PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3.
Chen D; Zhao Z; Chen L; Li Q; Zou J; Liu S
Cell Death Dis; 2021 Jul; 12(8):722. PubMed ID: 34290239
[TBL] [Abstract][Full Text] [Related]
7. SRSF3 Depletion Leads to an Increase in SF3B4 Expression in SNU-368 HCC Cells.
Lee J; Seo G; Hur W; Yoon SK; Nam SW; Lee JH
Anticancer Res; 2020 Apr; 40(4):2033-2042. PubMed ID: 32234894
[TBL] [Abstract][Full Text] [Related]
8. SRSF3 and HNRNPH1 Regulate Radiation-Induced Alternative Splicing of Protein Arginine Methyltransferase 5 in Hepatocellular Carcinoma.
Wen C; Tian Z; Li L; Chen T; Chen H; Dai J; Liang Z; Ma S; Liu X
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499164
[TBL] [Abstract][Full Text] [Related]
9. A Coiled-Coil Domain Containing 50 Splice Variant Is Modulated by Serine/Arginine-Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling Pathway.
Wang H; Zhang CZ; Lu SX; Zhang MF; Liu LL; Luo RZ; Yang X; Wang CH; Chen SL; He YF; Xie D; Xu RH; Yun JP
Hepatology; 2019 Jan; 69(1):179-195. PubMed ID: 30028541
[TBL] [Abstract][Full Text] [Related]
10. Loss of SRSF3 in Cardiomyocytes Leads to Decapping of Contraction-Related mRNAs and Severe Systolic Dysfunction.
Ortiz-Sánchez P; Villalba-Orero M; López-Olañeta MM; Larrasa-Alonso J; Sánchez-Cabo F; Martí-Gómez C; Camafeita E; Gómez-Salinero JM; Ramos-Hernández L; Nielsen PJ; Vázquez J; Müller-McNicoll M; García-Pavía P; Lara-Pezzi E
Circ Res; 2019 Jul; 125(2):170-183. PubMed ID: 31145021
[TBL] [Abstract][Full Text] [Related]
11. Loss of SRSF2 triggers hepatic progenitor cell activation and tumor development in mice.
Zhang C; Shen L; Yuan W; Liu Y; Guo R; Luo Y; Zhan Z; Xie Z; Wu G; Wu W; Feng Y
Commun Biol; 2020 May; 3(1):210. PubMed ID: 32372053
[TBL] [Abstract][Full Text] [Related]
12. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
Yang S; Jia R; Bian Z
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma.
Webster NJG; Kumar D; Wu P
Sci Rep; 2024 Jan; 14(1):2500. PubMed ID: 38291075
[TBL] [Abstract][Full Text] [Related]
14. Splicing factor SRSF3 is crucial for hepatocyte differentiation and metabolic function.
Sen S; Jumaa H; Webster NJ
Nat Commun; 2013; 4():1336. PubMed ID: 23299886
[TBL] [Abstract][Full Text] [Related]
15. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
16. Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair.
He X; Zhang P
Mol Cancer; 2015 Aug; 14():158. PubMed ID: 26282282
[TBL] [Abstract][Full Text] [Related]
17. Construction and evaluation of an adenoviral vector for the liver-specific expression of the serine/arginine-rich splicing factor, SRSF3.
Suchanek AL; Salati LM
Plasmid; 2015 Nov; 82():1-9. PubMed ID: 26241824
[TBL] [Abstract][Full Text] [Related]
18. SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.
Wang ZW; Pan JJ; Hu JF; Zhang JQ; Huang L; Huang Y; Liao CY; Yang C; Chen ZW; Wang YD; Shen BY; Tian YF; Chen S
Cell Rep; 2022 May; 39(6):110813. PubMed ID: 35545048
[TBL] [Abstract][Full Text] [Related]
19. Liver insulin-like growth factor 2 methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinoma.
Couvert P; Carrié A; Pariès J; Vaysse J; Miroglio A; Kerjean A; Nahon P; Chelly J; Trinchet JC; Beaugrand M; Ganne-Carrié N
World J Gastroenterol; 2008 Sep; 14(35):5419-27. PubMed ID: 18803353
[TBL] [Abstract][Full Text] [Related]
20. Serine arginine splicing factor 3 is involved in enhanced splicing of glucose-6-phosphate dehydrogenase RNA in response to nutrients and hormones in liver.
Walsh CM; Suchanek AL; Cyphert TJ; Kohan AB; Szeszel-Fedorowicz W; Salati LM
J Biol Chem; 2013 Jan; 288(4):2816-28. PubMed ID: 23233666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
